Anti-parasitic drug prevents pancreatic cancer’s initiation, progression and metastasis in mice – News-Medical.Net

As the third-most lethal cancer in the United States, with only a 1% five-year survival rate for people with its most aggressive form, pancreatic cancer has long been a target of researchers who search for ways to slow or stop its growth and spread. Now,…

Click here to view the original article.